chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Intermittent pain; Elevated C-reactive Protein; Burning sensation on the chest; Knee worse; Tingling of the legs; Breath Soreness; Extreme dehydration; Runny nose; weird pain; Exhaustion; Weird Pain/Excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), PAIN (weird pain), PARAESTHESIA (Tingling of the legs), PAIN (Breath Soreness) and DEHYDRATION (Extreme dehydration) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ALPRAZOLAM (ZOLAX [ALPRAZOLAM]) for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced RHINORRHOEA (Runny nose), PAIN (weird pain), FATIGUE (Exhaustion) and MYALGIA (Weird Pain/Excruciating pain). On 13-Apr-2021, the patient experienced PARAESTHESIA (Tingling of the legs), PAIN (Breath Soreness), DEHYDRATION (Extreme dehydration), CHEST PAIN (Burning sensation on the chest) and ARTHRALGIA (Knee worse). On 16-Apr-2021, the patient experienced C-REACTIVE PROTEIN INCREASED (Elevated C-reactive Protein). On an unknown date, the patient experienced PAIN (Intermittent pain). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 22-Mar-2021, RHINORRHOEA (Runny nose), PAIN (weird pain) and FATIGUE (Exhaustion) had resolved. At the time of the report, PARAESTHESIA (Tingling of the legs), PAIN (Breath Soreness), DEHYDRATION (Extreme dehydration), C-REACTIVE PROTEIN INCREASED (Elevated C-reactive Protein), CHEST PAIN (Burning sensation on the chest), PAIN (Intermittent pain), ARTHRALGIA (Knee worse) and MYALGIA (Weird Pain/Excruciating pain) outcome was unknown. Not Provided
Ever since my flu injection on 11/21/2016 directly into my left shoulder joint, pain has been increasing on a daily basis. A sore developed in the joint and surrounding deltoid region. My sleep patterns have been interrupted up to 10-20 times a night due to discomfort and pain. I feel to be aging rapidly since this incident. My high school students have commented to this effect. I have felt tearing in my shoulder joint on multiple occasions, as my shoulder strength is weakening, my daily activities of distance swimming and golf have virtually ceased due to this injection. I've had an MRI which verifies tendonitis and inflammation and SLAP tears of the rotator cuff. Infraspinatus tear. PT results in inflammation.
Onset 11/13/2009: chills, Rigor's Lethargy, Tachycardia. Seen at ED 11/15/09 - without Tx. Per mother child still symptomatic as of 11/17/09 - Advised to seek med Tx today.
Right after vaccination patient developed a metallic taste in mouth and became warm. Recipient was evaluated by on-site EMS and was stable and denied transportation to the hospital.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age. On 18-JUL-2012 the patient was vaccinated with the first dose of GARDASIL (0.5 ml, intramuscular, lot # was unknown) and the second dose of GARDASIL (0.5 ml, intramuscular, lot # was unknown) given on 19-OCT-2012. The Registered Nurse reported the third dose of GARDASIL (0.5 ml, intramuscular, lot # was unknown) was given early on 28-DEC-2012. No adverse effect reported. The outcome of event was unknown. Additional information is not expected.
Chills, Large Red Rash on Right Arm, Swollen Painful Lymph Nodes, Lost Of Appetite, Vomiting, Diarrhea
localized edema & redness to inject site; seen 5 days p/inject 4-5 cm diameter redness, edematous lesion @ inject site-hard w/minimal tenderness-lt deltoid;
Muscle aches, joint pain, headache, nausea, weakness. Lasted ~24 hours.
Systemic: TIA per emergency room md-Severe, Additional Details: Patient went to ER on 1/4, stayed overnight in hospital. Was told he had a TIA. Patient felt this should be reported.
Approximately 24 hours after given 2nd covid vaccine injection patient was sitting at bedside of a family member that came to hospital ED. She passed out and fell to floor. Lost her pulse and ED staff began CPR. She got her pulse back and woke up and said I am okay. Doctor seeing her ordered labs, EKG, Echocardiogram , chest xray, cardiac enzymes. All tests were normal. ED doctor told patient the only thing they could contribute this to was her covid vaccine she got the day before. She was admitted to the facility for further observation for the next 24 hours.
legs and feet cramping; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (legs and feet cramping) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included APIXABAN (ELIQUIS), AMLODIPINE and SPIRONOLACTONE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced MUSCLE SPASMS (legs and feet cramping). At the time of the report, MUSCLE SPASMS (legs and feet cramping) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Extreem headache, muscle pain, fatigue, Swolen Axillary lymph nodes on side shot was given
I did feel good for about a day after receiving the vaccine. I started not feeling well on 03/21/2023, I felt very tired and no energy. I tested positive for COVID-19 on 03/22/2023. I contacted the nurse at the clinic and was told I am not a candidate for PAXLOVID. I took over the counter medication to help with my symptoms. As of today, I have a stuffy head and runny nose.
Fever at ten days post immunization of Tmax 104.0f. Rash/hives to trunk/axilla/inguinal area/face/chin and torso.
Pt recvd 3rd DTP & became irritable & temp inc to 104.5 R; pt was then seen in ER-site of inject is markedly red & inflammed; no sz activity reported;
patient was lightheaded, vertigo and tingly 5 minutes after vaccine. States she felt worse 15 minutes later but declined epinephrine or medics. 25 minutes after vaccine took Zofran that she had in her purse and felt recovered enough to drive home by 35 minutes post vaccination
10 day Migraine and all over body aches and soreness, only relieved by steroid, muscle relaxer and botox injections, and anti inflammatory medications, sensitivity to bright lights and sounds, radiating warmth in core of body but cold extremities, severe fatigue and lethargy and  irritability.  Ringing in ears is loud.
it's a little red, dark pink, feels hot, it's swollen a little bit too; it's a little red, dark pink, feels hot, it's swollen a little bit too; it's a little red, dark pink, feels hot, it's swollen a little bit too; it's a little red, dark pink, feels hot, it's swollen a little bit too; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (it's a little red, dark pink, feels hot, it's swollen a little bit too), VACCINATION SITE WARMTH (it's a little red, dark pink, feels hot, it's swollen a little bit too), VACCINATION SITE SWELLING (it's a little red, dark pink, feels hot, it's swollen a little bit too) and VACCINATION SITE ERYTHEMA (it's a little red, dark pink, feels hot, it's swollen a little bit too) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (it's a little red, dark pink, feels hot, it's swollen a little bit too), VACCINATION SITE WARMTH (it's a little red, dark pink, feels hot, it's swollen a little bit too), VACCINATION SITE SWELLING (it's a little red, dark pink, feels hot, it's swollen a little bit too) and VACCINATION SITE ERYTHEMA (it's a little red, dark pink, feels hot, it's swollen a little bit too). At the time of the report, VACCINATION SITE DISCOLOURATION (it's a little red, dark pink, feels hot, it's swollen a little bit too), VACCINATION SITE WARMTH (it's a little red, dark pink, feels hot, it's swollen a little bit too), VACCINATION SITE SWELLING (it's a little red, dark pink, feels hot, it's swollen a little bit too) and VACCINATION SITE ERYTHEMA (it's a little red, dark pink, feels hot, it's swollen a little bit too) had not resolved.    Action taken with mRNA-1273 in response to the events was not applicable.   No concomitant medications provided  No treatment medications provided
7 days after first vaccine, started to experience palpitations, and what appeared to me feeling my pulse on my arm as missed heart beats. They were very slow. We have a Blood Pressure Machine at the hose, and I took my pressure. It was normal but my heart rate was 44, did it several times and the highest it went was 49, also the Blood pressure machine indicated I was having an irregular heartbeat.  I called my  family doctor that morning and they had me come into the office, and they did an EKG , and got the same results . I was sent to a heart doctor two days later, and I was still experiencing these issues. I had a stress test done which showed everything was normal.  But last week June 7th, had these palpitations again. The heart doctor only said maybe it's your inhaler. I saw my family doctor today and she indicated that this is not from an inhaler. I did mention the time line of the Covid vaccine and the heart issues, and she did not rule that out either.
Patient experienced numbness in 3 fingers on her left hand after getting the first dose of the vaccines about 10 minutes after the shot. The numbness started to subside the longer she sat there.
About two hours post vaccination pt. experienced severe pain in (L) arm. Went to ER via emergency squad. Was treated with analgesics and released to home with p.o. analgesia. By Monday 12-12-11 arm was still a "little sore" but diminishing.
2/26/21 @ 1150 Pt in 15min waiting area following administration of moderna 2nd dose. Approx. 5min into wait the pt wife reported something was wrong. Pt was pale, shaking, non responsive and urinated on himself during this event. Pulse was present. Within moments pt became responsive and answering questions.  Ambulance arrived, preformed assessment, advised to go to hospital. Pt refused. Pt remained coherent and without complaints.
After administration pt felt weak, leaned against wall and slumped to floor (No LOC) Acute laryngospasm - given epinephrine 0.3 mg SQ BENADRYL 50 mg PO and BENADRYL 25 mg IM - improved..
Report 2001021419-1 described swelling at injection site in a four year old female who received Infanrix. This report was received from a medical assistant and has not been verified by a physician or another health care professional. Reportedly, the vaccinee had no allergies, medical history, or concomitant medications. Reportedly, the vaccinee had no illness at the time of vaccination. On 08/03/2001, the vaccinee received a 0.5ml IM dose of Infanrix; it was not known whether the vaccinee had received previous doses of Infanrix. Reportedly, subsequently, she experienced redness at injection site, swelling at injection site and fever. Reportedly, the vacicnee was found to have cellulitis "due to the injection." Reportedly, the vaccinee was treated wtih Keflex 250mg four times daily orally starting on 08/06/2001. Her symptoms resolved. The reporter stated that 'the child has not received any other doses of Infanrix because she is caught up on her vaccations at this time." The reporter stated that the adverse events were mild and were related to Infanrix. As of 10/08/2001, symptoms had resolved.
Developed first time shingles less than a week after second dose; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included morbidly obese, tachycardia, sleep apnea, eosinophilic esophagitis (EoE), chronic migraine, depression, anxiety, seafood allergy (smoked salmon) and allergy to nuts (some nuts). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA), bupropion hydrochloride (WELLBUTRIN), propranolol (MANUFACTURER UNKNOWN) and pantoprazole (MANUFACTURER UNKNOWN) for unknown indication for unspecified date. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 13:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 15:00, the patient developed first time shingles less than a week after second dose. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles which included treatment with antiviral medication and prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles less than a week after second dose was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Post first vax, one week later, he experienced feeling achy all over his body and swelling of his right index and right ring finger and swelling left index and middle finger. The pt was treated with aspirin.
Itchy pink hives on torso, chest, both underarms, back and buttocks, hips
RED RASH OVER THE ENTIRE BODY AREA AND THEN PROGRESSED TO ITCHING AND WARM TO THE TOUCH
Headaches, nausea, generalized muscle aches, dizziness, tinnitus, palpitations, and considerable fatigue after being vaccinated. Due to continued complaints of dizziness and tinnitus, he was seen at Hospital's Ed where he was Dx: Vertigo, dizziness, vaccination complication
Patient  has developed a bad cough, which has worsened over time.  Now her breathing is becoming more difficult.
Heart rate increased; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient just wanted to get medical information because patient had the Pfizer Vaccine (Unspecified vaccine) done on Thursday last week and the next day patient had an increased heart rate and patient wanted to know if it was the side effect that had been happening with or someone could tell about that. Patient wanted to know if patient should take the second shot or it has happened to other people. Outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 26-JAN-2016, the patient was vaccinated with an improperly stored dose of VAQTA 10 Pk 25 U/0.5 ml SD Llok Cap Ped, which had the lot # L001445, with expiration date 15-FEB-2016 (dose, dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On an unspecified date the vaccine experienced a temperature excursions of 624 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator (R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Diarrhea comes and goes; Heavy nightmares; Palpitations; Body has felt a little off; Bad headaches; Arm felt heavy and painful; Arm felt heavy; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and PAIN IN EXTREMITY (Arm felt heavy and painful) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (darvacet and darvan.) and Blood pressure high. Concomitant products included LOSARTAN, VITAMIN D3 and CORTISONE for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy) and PYREXIA (Fever). On 15-Jan-2021, the patient experienced DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and HEADACHE (Bad headaches). At the time of the report, DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off), PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy), PYREXIA (Fever) and HEADACHE (Bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
nausea at 8:30 pm day following  vaccine, vomitting at 10pm, 11pm.  (11/7/21) nausea next morning, with vomitting at 8:15am (11/8/21)
I had a back problem at the time and the first sympton was increased and unbearable pain in my back.  On or about 11/02/2007, I developed weakness in my legs and a numbness started spreading throughout my body.  I went to the emergency room and was admitted to the hospital.  At the time of admission, my face, legs, chest and back was numb and I had slurred speech.  I then totally loss use of both legs and was not even able to stand on my own.  A few days later, Dr. diagnosed my problem as Guillain Barre Syndrome and began treatment with intravenous immune globulin.  11/19/09 Neurology consultation records received service dates 11/12/07 to 12/11/2007. Assessment: Guillain-Barre Syndrome. Six week history of pain in legs, numbness anterior thigh and pelvis. Patient developed substernal chest pain, pressure sensation, and presented at ED. Some nausea and vomiting. Later, while in the hospital, fell and needed help getting into bed. Difficulty ambulating. Weakness has progressed. Difficulty griping with left hand. Weakness in hands. Dysarthric. Bilateral facial weakness. Muscle weakness. Areflexia (R) knee and ankle, (R) upper extremity, 1+ left extremity. Cold sensation decreased to T8-T6. Constipation. Lumbar stenosis. Paresthesias all 4 extremities. Sinus tachycardia.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history was not reported. On 06-APR-2015, the patient was received improperly stored VARIVAX (Merck) (lot # K005427, exp date 15-APR-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
Information has been received from a physician concerning an 18 year old female who on 29-SEP-2007 was vaccinated with her third dose of Gardasil. On 30-SEP-2007, the patient developed a fever, vomiting, throat swelling and arthralgias. The physician indicated that the patient had the same non-severe reaction to the previous two vaccinations (dates unspecified). Additional information has been requested.
HIVES/ GROWING CLUSTER THAT STARTED ON THE FOREHEAD AND WENT DOWN THE CHEEKS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced hives/ growing cluster that started on the forehead and went down the cheeks. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of hives/ growing cluster that started on the forehead and went down the cheeks was not reported. This report was non-serious.
Patient received unknown covid vaccine 1/20/21, sometime before or after became Covid PCR+. 3 days later developed encephalopathy, was quite agitated, walking around hospital naked. He had LP which ruled out infection and CT imaging to rule out CVA. Improved after 24 hrs with supportive care, pt returned to mental status baseline
Last night I noticed injection site was raised and swollen about 1-2 inches. This morning it was larger both in diameter and swelling. No pain. A little itchy. I've always had headaches this past week almost daily but could not rule out computer eye strain and not drinking enough water.
myocarditis; Initial information received on 27-Jan-2022 regarding an unsolicited valid social media serious case received from a consumer/non-hcp via social media.  This case involves a 21 years old male patient who had myocarditis while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (frequency, formulation, route, strength, lot number and expiry date were unknown) via unknown administration site for prophylactic vaccination. Information for the batch and expiry date was requested.  On an unknown date the patient had myocarditis (latency: unknown). This event was assessed as medically significant.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (myocarditis).  At time of reporting, the outcome was Unknown for the event myocarditis.; Sender's Comments: Sanofi company dated: 27-Jan-2022: This case involves 21-year-old male patient who had myocarditis with influenza Vaccine (Manufacturer unknown). The time to onset is not reported with the role of the vaccine. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, role of medical history, concomitants, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of an individual vaccine cannot be assessed.